185 related articles for article (PubMed ID: 35716271)
1. Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease.
Schmitz M; Canaslan S; Espinosa JC; Fernández-Borges N; Villar-Piqué A; Llorens F; Varges D; Maass F; Torres JM; Hermann P; Zerr I
Mol Neurobiol; 2022 Sep; 59(9):1-9. PubMed ID: 35716271
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
[TBL] [Abstract][Full Text] [Related]
3. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.
Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Rossi M; Polischi B; Capellari S; Parchi P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791145
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias.
Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Polischi B; Capellari S; Parchi P
Alzheimers Res Ther; 2023 Sep; 15(1):150. PubMed ID: 37684653
[TBL] [Abstract][Full Text] [Related]
7. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S
Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.
Thompson AGB; Luk C; Heslegrave AJ; Zetterberg H; Mead SH; Collinge J; Jackson GS
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):955-961. PubMed ID: 29487167
[TBL] [Abstract][Full Text] [Related]
10. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
11. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Mok TH; Nihat A; Majbour N; Sequeira D; Holm-Mercer L; Coysh T; Darwent L; Batchelor M; Groveman BR; Orr CD; Hughson AG; Heslegrave A; Laban R; Veleva E; Paterson RW; Keshavan A; Schott JM; Swift IJ; Heller C; Rohrer JD; Gerhard A; Butler C; Rowe JB; Masellis M; Chapman M; Lunn MP; Bieschke J; Jackson GS; Zetterberg H; Caughey B; Rudge P; Collinge J; Mead S
Brain; 2023 Jun; 146(6):2570-2583. PubMed ID: 36975162
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
13. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease.
Halbgebauer S; Abu-Rumeileh S; Oeckl P; Steinacker P; Roselli F; Wiesner D; Mammana A; Beekes M; Kortazar-Zubizarreta I; Perez de Nanclares G; Capellari S; Giese A; Castilla J; Ludolph AC; Žáková D; Parchi P; Otto M
Neurology; 2022 Apr; 98(14):e1434-e1445. PubMed ID: 35110380
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
Schmitz M; Llorens F; Pracht A; Thom T; Correia Â; Zafar S; Ferrer I; Zerr I
Aging (Albany NY); 2016 Nov; 8(11):2927-2935. PubMed ID: 27852982
[TBL] [Abstract][Full Text] [Related]
15. Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease.
Yakovleva O; Bett C; Pilant T; Asher DM; Gregori L
J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35816369
[TBL] [Abstract][Full Text] [Related]
16. Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.
Singh A; Beveridge AJ; Singh N
PLoS One; 2011 Mar; 6(3):e16804. PubMed ID: 21408069
[TBL] [Abstract][Full Text] [Related]
17. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt-Jakob disease: a (network) meta-analysis.
Rübsamen N; Pape S; Konigorski S; Zapf A; Rücker G; Karch A
Eur J Neurol; 2022 May; 29(5):1366-1376. PubMed ID: 35075751
[TBL] [Abstract][Full Text] [Related]
20. Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.
Llorens F; Kruse N; Karch A; Schmitz M; Zafar S; Gotzmann N; Sun T; Köchy S; Knipper T; Cramm M; Golanska E; Sikorska B; Liberski PP; Sánchez-Valle R; Fischer A; Mollenhauer B; Zerr I
Mol Neurobiol; 2018 Mar; 55(3):2249-2257. PubMed ID: 28321768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
